PATENT CLAIM ANALYSIS

Application Number: 16008219
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "456000"]

Abstract:
Disclosed are the uses of compositions containing not less than 10% w/w of Oroxylin A, not less than 10% w/w of Baicalein and not less than 2% w/w of Chrysin in inhibiting the activity and expression of β secretase. The invention also discloses the reduction of amyloid content in PS-70 cells using the abovementioned composition. Further, the invention mentions the use of the composition for the therapeutic management of β secretase mediated disorders.

Claim (Index 3):
A method of inhibiting the expression of \u03b2 secretase, said method comprising step of bringing in to contact mammalian cells with a composition containing not less than 10% w/w of oroxylin A, not less than 10% w/w of baicalein and not less than 2% w/w of chrysin, to bring about the effect of decreasing the expression of \u03b2 secretase enzyme.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.7234
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15805320', '13377508', '14855065', '11523507', '10480954']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7397792831540124
- 35 USC 102 Novelty (BERT): 0.5089243955956856
- Combined Prediction Score: 0.7166937943981798
- Mean Citation Score: 201.282908
- Max Citation Score: 248.95978
- Similarity Product: 157.2229103821564

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test